Change region


Carprieve® (carprofen) Chewable Tablets

Carprieve® (carprofen) Chewable Tablets from Norbrook® is the generic form of the most commonly prescribed NSAID for dogs worldwide with an excellent reputation for safety and efficacy. Carprofen remains the veterinarians’ first choice for relief of pain and inflammation associated with osteoarthritis (OA) and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.

Product Attributes

Bioequivalent to the pioneer product, Rimadyl® (carprofen) Chewable Tablets 

• Less expensive than Rimadyl Chewable Tablets, offering significant savings and improved clinic profit potential

• Flexible dosing: Administer to dogs at 2 mg/lb (4.4 mg/kg) of body weight daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily

• Available in 25 mg, 75 mg and 100 mg strengths

• Available in 30, 60 and 180 count bottles


As a class, NSAIDS may be associated with gastrointestinal, kidney and liver side effects. These are usually mild, but may be serious. Dog owners should discontinue therapy and contact their veterinarian immediately if side effects occur. Evaluation for pre-existing conditions and regular monitoring are recommended for dogs on any medication, including Carprieve. Use with other NSAIDS or corticosteroids should be avoided. See full product labeling for full product information.

© 2023 Norbrook Laboratories Limited. The Norbrook logo and Carprieve are registered trademarks of Norbrook Laboratories Limited. Rimadyl is a registered trademark of Zoetis, Inc.


To learn more, contact us at 866-591-5777. To place an order, contact your veterinarian or distributor. 


Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.